周三盘前，直觉外科公司股价大涨7.57%。尽管多家投行下调了该公司的目标价，但股价仍出现上涨，可能是由于市场对公司前景的担忧已经部分反映在之前的股价中。
据报道，包括摩根大通、杰富瑞、BTIG和加拿大皇家银行在内的多家投行纷纷下调了直觉外科的目标价。其中，摩根大通将目标价从675美元下调至605美元，杰富瑞从582美元下调至530美元，BTIG从560美元下调至542美元，加拿大皇家银行则从630美元下调至605美元。
尽管面临目标价下调的压力，直觉外科的股价仍然出现大幅上涨。这可能表明，投资者认为此前的担忧已经过度反映在股价中，现在的估值可能更具吸引力。同时，市场可能也在关注该公司未来的业绩表现和行业地位，期待其在医疗机器人领域保持领先优势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.